HCW Biologics Inc. (HCWB)
NASDAQ: HCWB · Real-Time Price · USD
0.710
-0.238 (-25.08%)
At close: Nov 21, 2024, 4:00 PM
0.735
+0.025 (3.58%)
After-hours: Nov 21, 2024, 5:03 PM EST
HCW Biologics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 1 | 3.6 | 22.33 | 11.73 | 8.46 | 7.36 |
Short-Term Investments | - | - | 9.74 | 24.98 | - | - |
Cash & Short-Term Investments | 1 | 3.6 | 32.06 | 36.71 | 8.46 | 7.36 |
Cash Growth | -91.10% | -88.79% | -12.67% | 334.19% | 14.95% | - |
Accounts Receivable | 0.65 | 1.54 | 0.42 | - | 2.5 | - |
Other Receivables | - | - | - | 0.13 | - | - |
Receivables | 0.65 | 1.54 | 0.42 | 0.13 | 2.5 | - |
Prepaid Expenses | 0.36 | 1.04 | 1.39 | 2.2 | 0.54 | 0.44 |
Other Current Assets | 0.09 | 0.23 | 0.2 | 1.44 | 0.65 | 0.24 |
Total Current Assets | 2.09 | 6.4 | 34.07 | 40.48 | 12.15 | 8.03 |
Property, Plant & Equipment | 22.83 | 20.48 | 10.8 | 1.12 | 1.62 | 2 |
Long-Term Investments | 1.6 | 1.6 | 1.6 | 11.52 | 1.6 | - |
Other Long-Term Assets | 0.03 | 0.03 | 0.33 | 0.39 | 0.03 | 0.03 |
Total Assets | 26.56 | 28.51 | 46.81 | 53.51 | 15.4 | 10.07 |
Accounts Payable | 22.67 | 6.17 | 1.23 | 0.22 | 0.16 | 0.39 |
Accrued Expenses | 1.18 | 2.43 | 1.55 | 0.3 | 0.28 | 0.67 |
Short-Term Debt | - | - | - | - | 0.57 | - |
Current Portion of Long-Term Debt | - | 0.12 | - | - | - | - |
Current Portion of Leases | - | 0.03 | 0.18 | - | - | - |
Current Unearned Revenue | - | - | - | 1.8 | - | - |
Total Current Liabilities | 23.85 | 8.75 | 2.96 | 2.32 | 1 | 1.07 |
Long-Term Debt | 12.68 | 6.3 | 6.41 | - | - | - |
Long-Term Leases | - | - | 0.01 | - | - | - |
Total Liabilities | 36.53 | 15.05 | 9.38 | 2.32 | 1 | 1.07 |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | 87.21 | 83.99 | 82.96 | 81.83 | - | - |
Retained Earnings | -97.18 | -70.53 | -45.54 | -30.64 | -16.72 | -9.68 |
Total Common Equity | -9.97 | 13.46 | 37.43 | 51.19 | -16.72 | -9.68 |
Shareholders' Equity | -9.97 | 13.46 | 37.43 | 51.19 | 14.4 | 9 |
Total Liabilities & Equity | 26.56 | 28.51 | 46.81 | 53.51 | 15.4 | 10.07 |
Total Debt | 12.68 | 6.45 | 6.6 | - | 0.57 | - |
Net Cash (Debt) | -11.68 | -2.86 | 25.46 | 36.71 | 7.89 | 7.36 |
Net Cash Growth | - | - | -30.65% | 365.41% | 7.24% | - |
Net Cash Per Share | -0.31 | -0.08 | 0.71 | 1.96 | 1.66 | 1.72 |
Filing Date Shares Outstanding | 37.82 | 37.82 | 35.89 | 35.78 | 4.79 | 4.29 |
Total Common Shares Outstanding | 37.82 | 36.03 | 35.88 | 35.77 | 4.79 | 4.29 |
Working Capital | -21.75 | -2.34 | 31.11 | 38.16 | 11.15 | 6.96 |
Book Value Per Share | -0.26 | 0.37 | 1.04 | 1.43 | -3.49 | -2.26 |
Tangible Book Value | -9.97 | 13.46 | 37.43 | 51.19 | -16.72 | -9.68 |
Tangible Book Value Per Share | -0.26 | 0.37 | 1.04 | 1.43 | -3.49 | -2.26 |
Land | - | 2.15 | 2.15 | - | - | - |
Buildings | - | 6.11 | 6.11 | - | - | - |
Machinery | - | 2.66 | 2.62 | 2.42 | 2.37 | 2.19 |
Construction In Progress | - | 10.44 | 0.05 | - | - | - |
Leasehold Improvements | - | 0.35 | 0.35 | 0.35 | 0.35 | 0.35 |
Source: S&P Capital IQ. Standard template. Financial Sources.